Overview Financials News + Filings Key Docs Charts Ownership Insiders |
ARGAN INC (AGX)
|
Add to portfolio |
|
|
Price: |
$39.37
| | Metrics |
OS: |
13.4
|
M
| |
|
|
Market cap: |
$528
|
M
| |
|
|
Net cash:
|
$317
|
M
| |
$23.63
|
per share
|
EV:
|
$211
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$42.7
|
M
| |
4.9
|
x EV/EBITDA
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 | Jan-31-18 | Jan-31-17 | Jan-31-16 | Jan-31-15 |
Revenues | 509.4 | 392.2 | 239.0 | 482.2 | 892.8 | 675.0 | 413.3 | 383.1 |
Revenue growth | 29.9% | 64.1% | -50.4% | -46.0% | 32.3% | 63.3% | 7.9% | 68.4% |
Cost of goods sold | 409.6 | 330.1 | 245.8 | 399.7 | 743.5 | 528.3 | 313.8 | 299.5 |
Gross profit | 99.7 | 62.1 | -6.8 | 82.4 | 149.3 | 146.7 | 99.5 | 83.6 |
Gross margin | 19.6% | 15.8% | -2.9% | 17.1% | 16.7% | 21.7% | 24.1% | 21.8% |
Selling, general and administrative | 47.3 | 39.0 | 44.1 | 40.7 | 41.8 | 32.5 | 25.1 | 19.5 |
EBITA | 53.3 | 23.9 | -49.8 | 42.7 | 108.6 | 115.4 | 74.9 | 64.4 |
EBITA margin | 10.5% | 6.1% | -20.8% | 8.9% | 12.2% | 17.1% | 18.1% | 16.8% |
Amortization of intangibles | 0.9 | 0.9 | 1.1 | 1.0 | 1.0 | 1.2 | 0.5 | 0.2 |
EBIT | 52.4 | 23.0 | -50.9 | 41.7 | 107.6 | 114.2 | 74.4 | 64.1 |
EBIT margin | 10.3% | 5.9% | -21.3% | 8.7% | 12.0% | 16.9% | 18.0% | 16.7% |
Pre-tax income | 47.1 | 24.9 | -47.8 | 47.2 | 112.6 | 114.5 | 75.5 | 64.4 |
Income taxes | 11.4 | 1.1 | -7.1 | -4.7 | 40.3 | 37.1 | 25.3 | 20.9 |
Tax rate | 24.1% | 4.3% | 14.8% | | 35.8% | 32.4% | 33.5% | 32.5% |
Net income | 38.2 | 23.9 | -42.7 | 52.0 | 72.0 | 70.3 | 36.3 | 30.4 |
Net margin | 7.5% | 6.1% | -17.9% | 10.8% | 8.1% | 10.4% | 8.8% | 7.9% |
|
Diluted EPS | $2.40 | $1.51 | ($2.73) | $3.32 | $4.56 | $4.50 | $2.42 | $2.05 |
Shares outstanding (diluted) | 15.9 | 15.8 | 15.6 | 15.7 | 15.8 | 15.6 | 15.0 | 14.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|